Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult

Jeffrey P. Moak, Derek Leong, Robin Fabian, Vicki Freedenberg, Elizabeth Jarosz, Carol Toney, Sridhar Hanumanthaiah, Anil Darbari

Research output: Contribution to journalArticle

Abstract

Orthostatic intolerance (OI) is common in teenagers (T) and young adults (A). Despite treatment with oral fluids, medication, and exercise, a significant number have symptoms from multiple organ systems and suffer low quality of life (QOL). Previous studies showed that acute intravenous (IV) hydration (IH) could help restore orthostatic tolerance; however, no data are available about the intermediate-term effects of IH. We therefore studied the efficacy of IH to improve QOL and manage medication-refractory OI patients. Our study population consisted of 39 patients (mean age = 16.1 ± 3.3) years; thirty-two were female. Average number of medications failed = 3.1. Average QOL score on self-reported OI questionnaire was 4.2 (normal QOL = 10). IV hydration consisted of normal saline (1–2 l/day, 3–7 days/week). 1) Orthostatic testing revealed Postural Orthostatic Tachycardia (24), Neurally Mediated Hypotension (14) or OI (1). 2) Average orthostatic change in heart rate was 48 ± 18 bpm. 3) IH was performed via intermittent IV access (10), PICC line (22), and Port (7). 4) Duration of IH varied from 1 week to 3.8 years (mean = 29 ± 47 weeks). 5) Overall, 79 % (n = 31) demonstrated clinically improved self-reported QOL. 6) Six patients who discontinued IH requested to restart treatment. (7) Complications consisted of upper extremity deep vein thrombosis (n = 3) and infection (n = 4). IH is an effective therapy to improve QOL in T&A with medication-resistant OI. Most patients continued to report improved QOL once IH was discontinued. IH should be considered a therapeutic option in medication-resistant OI patients with low QOL.

Original languageEnglish (US)
Pages (from-to)278-282
Number of pages5
JournalPediatric Cardiology
Volume37
Issue number2
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

Orthostatic Intolerance
Young Adult
Quality of Life
Upper Extremity Deep Vein Thrombosis
Therapeutics
Tachycardia
Hypotension
Heart Rate
Exercise

Keywords

  • Children
  • Intravenous hydration
  • Orthostatic intolerance
  • Postural Orthostatic Tachycardia Syndrome
  • Quality of life

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Moak, J. P., Leong, D., Fabian, R., Freedenberg, V., Jarosz, E., Toney, C., ... Darbari, A. (2016). Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult. Pediatric Cardiology, 37(2), 278-282. https://doi.org/10.1007/s00246-015-1274-6

Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult. / Moak, Jeffrey P.; Leong, Derek; Fabian, Robin; Freedenberg, Vicki; Jarosz, Elizabeth; Toney, Carol; Hanumanthaiah, Sridhar; Darbari, Anil.

In: Pediatric Cardiology, Vol. 37, No. 2, 01.02.2016, p. 278-282.

Research output: Contribution to journalArticle

Moak, JP, Leong, D, Fabian, R, Freedenberg, V, Jarosz, E, Toney, C, Hanumanthaiah, S & Darbari, A 2016, 'Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult', Pediatric Cardiology, vol. 37, no. 2, pp. 278-282. https://doi.org/10.1007/s00246-015-1274-6
Moak, Jeffrey P. ; Leong, Derek ; Fabian, Robin ; Freedenberg, Vicki ; Jarosz, Elizabeth ; Toney, Carol ; Hanumanthaiah, Sridhar ; Darbari, Anil. / Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult. In: Pediatric Cardiology. 2016 ; Vol. 37, No. 2. pp. 278-282.
@article{9c48272dadc245818104b615dd4866e7,
title = "Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult",
abstract = "Orthostatic intolerance (OI) is common in teenagers (T) and young adults (A). Despite treatment with oral fluids, medication, and exercise, a significant number have symptoms from multiple organ systems and suffer low quality of life (QOL). Previous studies showed that acute intravenous (IV) hydration (IH) could help restore orthostatic tolerance; however, no data are available about the intermediate-term effects of IH. We therefore studied the efficacy of IH to improve QOL and manage medication-refractory OI patients. Our study population consisted of 39 patients (mean age = 16.1 ± 3.3) years; thirty-two were female. Average number of medications failed = 3.1. Average QOL score on self-reported OI questionnaire was 4.2 (normal QOL = 10). IV hydration consisted of normal saline (1–2 l/day, 3–7 days/week). 1) Orthostatic testing revealed Postural Orthostatic Tachycardia (24), Neurally Mediated Hypotension (14) or OI (1). 2) Average orthostatic change in heart rate was 48 ± 18 bpm. 3) IH was performed via intermittent IV access (10), PICC line (22), and Port (7). 4) Duration of IH varied from 1 week to 3.8 years (mean = 29 ± 47 weeks). 5) Overall, 79 {\%} (n = 31) demonstrated clinically improved self-reported QOL. 6) Six patients who discontinued IH requested to restart treatment. (7) Complications consisted of upper extremity deep vein thrombosis (n = 3) and infection (n = 4). IH is an effective therapy to improve QOL in T&A with medication-resistant OI. Most patients continued to report improved QOL once IH was discontinued. IH should be considered a therapeutic option in medication-resistant OI patients with low QOL.",
keywords = "Children, Intravenous hydration, Orthostatic intolerance, Postural Orthostatic Tachycardia Syndrome, Quality of life",
author = "Moak, {Jeffrey P.} and Derek Leong and Robin Fabian and Vicki Freedenberg and Elizabeth Jarosz and Carol Toney and Sridhar Hanumanthaiah and Anil Darbari",
year = "2016",
month = "2",
day = "1",
doi = "10.1007/s00246-015-1274-6",
language = "English (US)",
volume = "37",
pages = "278--282",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult

AU - Moak, Jeffrey P.

AU - Leong, Derek

AU - Fabian, Robin

AU - Freedenberg, Vicki

AU - Jarosz, Elizabeth

AU - Toney, Carol

AU - Hanumanthaiah, Sridhar

AU - Darbari, Anil

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Orthostatic intolerance (OI) is common in teenagers (T) and young adults (A). Despite treatment with oral fluids, medication, and exercise, a significant number have symptoms from multiple organ systems and suffer low quality of life (QOL). Previous studies showed that acute intravenous (IV) hydration (IH) could help restore orthostatic tolerance; however, no data are available about the intermediate-term effects of IH. We therefore studied the efficacy of IH to improve QOL and manage medication-refractory OI patients. Our study population consisted of 39 patients (mean age = 16.1 ± 3.3) years; thirty-two were female. Average number of medications failed = 3.1. Average QOL score on self-reported OI questionnaire was 4.2 (normal QOL = 10). IV hydration consisted of normal saline (1–2 l/day, 3–7 days/week). 1) Orthostatic testing revealed Postural Orthostatic Tachycardia (24), Neurally Mediated Hypotension (14) or OI (1). 2) Average orthostatic change in heart rate was 48 ± 18 bpm. 3) IH was performed via intermittent IV access (10), PICC line (22), and Port (7). 4) Duration of IH varied from 1 week to 3.8 years (mean = 29 ± 47 weeks). 5) Overall, 79 % (n = 31) demonstrated clinically improved self-reported QOL. 6) Six patients who discontinued IH requested to restart treatment. (7) Complications consisted of upper extremity deep vein thrombosis (n = 3) and infection (n = 4). IH is an effective therapy to improve QOL in T&A with medication-resistant OI. Most patients continued to report improved QOL once IH was discontinued. IH should be considered a therapeutic option in medication-resistant OI patients with low QOL.

AB - Orthostatic intolerance (OI) is common in teenagers (T) and young adults (A). Despite treatment with oral fluids, medication, and exercise, a significant number have symptoms from multiple organ systems and suffer low quality of life (QOL). Previous studies showed that acute intravenous (IV) hydration (IH) could help restore orthostatic tolerance; however, no data are available about the intermediate-term effects of IH. We therefore studied the efficacy of IH to improve QOL and manage medication-refractory OI patients. Our study population consisted of 39 patients (mean age = 16.1 ± 3.3) years; thirty-two were female. Average number of medications failed = 3.1. Average QOL score on self-reported OI questionnaire was 4.2 (normal QOL = 10). IV hydration consisted of normal saline (1–2 l/day, 3–7 days/week). 1) Orthostatic testing revealed Postural Orthostatic Tachycardia (24), Neurally Mediated Hypotension (14) or OI (1). 2) Average orthostatic change in heart rate was 48 ± 18 bpm. 3) IH was performed via intermittent IV access (10), PICC line (22), and Port (7). 4) Duration of IH varied from 1 week to 3.8 years (mean = 29 ± 47 weeks). 5) Overall, 79 % (n = 31) demonstrated clinically improved self-reported QOL. 6) Six patients who discontinued IH requested to restart treatment. (7) Complications consisted of upper extremity deep vein thrombosis (n = 3) and infection (n = 4). IH is an effective therapy to improve QOL in T&A with medication-resistant OI. Most patients continued to report improved QOL once IH was discontinued. IH should be considered a therapeutic option in medication-resistant OI patients with low QOL.

KW - Children

KW - Intravenous hydration

KW - Orthostatic intolerance

KW - Postural Orthostatic Tachycardia Syndrome

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84959150347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959150347&partnerID=8YFLogxK

U2 - 10.1007/s00246-015-1274-6

DO - 10.1007/s00246-015-1274-6

M3 - Article

C2 - 26446285

AN - SCOPUS:84959150347

VL - 37

SP - 278

EP - 282

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 2

ER -